Tango Therapeutics

Tango Therapeutics is a biotechnology company focused on discovering and developing novel cancer therapies by targeting genetic vulnerabilities. They utilize a precision oncology approach, leveraging synthetic lethality to identify and inhibit specific genetic interactions that are critical for cancer cell survival. Founded in 2017, Tango Therapeutics has made significant strides in the field, securing partnerships and funding to advance their pipeline of targeted treatments. Their revenue model primarily involves research and development collaborations, licensing agreements, and potential future product sales.

Recent Posts by Tango Therapeutics

1-20 of 114